Ventyx Biosciences Reports Second Quarter 2025 Financial Results and Highlights Recent Corporate Progress

Go back to Ventyx Biosciences Reports Second Quarter 2025 Financial Results and Highlights Recent Corporate Progress

Ventyx Biosciences, Inc. (VTYX) Tops Q2 EPS by 8c

August 7, 2025 4:20 PM EDT

Ventyx Biosciences, Inc. (NASDAQ: VTYX) reported Q2 EPS of ($0.38), $0.08 better than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Ventyx Biosciences, Inc. (VTYX) click here.

... More